About Technology Issues FAQ

Links

Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2− advanced breast cancer: results from BOLERO-2

Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2− advanced breast cancer: results from BOLERO-2 — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.